Liminatus Pharma, Inc. is a pre-clinical-stage immuno-oncology company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in La Palma, CA. The company trades on NASD exchange. The company headquarter is located in USA.

TickerLIMN
Long NameLiminatus Pharma Inc
Short NameLiminatus Pharma